PATENT CLAIM ANALYSIS

Application Number: 15986256
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "210180"]

Abstract:
Compounds of Formula (00A) and salts thereof, wherein R 1 , R 2  R 3 , R 4  and n are defined herein, are useful as inhibitors of one or more Janus kinases. Also provided are pharmaceutical compositions that include a compound of Formula (00A) and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.

Claim (Index 2):
The compound of  claim 1  wherein R 1  is H, \u2014(C 0 -C 3 alkyl)R a , (C 0 -C 3 alkyl)NR a R b , \u2014(C 0 -C 3 alkyl)C(O)R a , or \u2014(C 0 -C 3 alkyl)C(O)OR a , or a pharmaceutically acceptable salt or stereoisomer thereof.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 93.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15139164', '15984747', '14670421', '15861688', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8167160303786021
- 35 USC 102 Novelty (BERT): 0.5569557692240694
- Combined Prediction Score: 0.7907400042631488
- Mean Citation Score: 396.211206
- Max Citation Score: 435.32587
- Similarity Product: 347.3755300902325

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test